Kazakhstan plans to localize production of Pfizer and AstraZeneca drugs

The Kazakh authorities are waiting for Pfizer and AstraZeneca companies to start production of drugs in the country, Report informs, citing the press service of the Cabinet of Ministers.

Prime Minister of Kazakhstan Alikhan Smailov noted that the Government was also actively cooperating with major representatives of the global pharmaceutical industry, providing packages of state support measures. Thus, with Pfizer it is planned to conclude an Investment Agreement on localization of production of medicines. An agreement has been reached with AstraZeneca on the creation of contract manufacturing of original drugs with an investment volume of $32 million.

At the same time, within the framework of the visit of the President of the Republic of Kazakhstan to the USA, a framework agreement was signed with GE Healthcare on the localization of the production of medical equipment for the amount of $60 million. At the same time, a number of projects with the company Roсhe for the amount of $2.5 million are being worked out. At various stages of implementation, there are contract manufacturing projects with investors from South Korea, Türkiye, Egypt, and Israel.